Autologous BMT
Showing 1 - 25 of 4,057
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Nov 20, 2021
Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA
Recruiting
- Sickle Cell Disease
- Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
-
Los Angeles, California
- +8 more
Jan 10, 2023
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Multiple Myeloma Trial in United States (procedure, drug, behavioral)
Completed
- Multiple Myeloma
- One Autologous Transplant
- +5 more
-
Birmingham, Alabama
- +35 more
Oct 19, 2021
Stem Cell Transplant Complications, Myeloma, Lymphoma Trial in Cleveland (physical therapy consult, Cognitive Assessment, Cancer
Recruiting
- Stem Cell Transplant Complications
- +3 more
- physical therapy consult
- +8 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
May 24, 2022
GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))
Completed
- Graft Versus Host Disease
- +2 more
- Autologous mesenchymal stromal cells (MSCs)
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Mar 2, 2021
Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)
Completed
- Multiple Myeloma
- Lenalidomide
- lenalidomide, bortezomib and dexamethasone
-
Tucson, Arizona
- +53 more
Dec 8, 2021
Breast Tumors Trial in Oklahoma City (High-Dose Chemo with Autologous BMT)
Completed
- Breast Neoplasms
- High-Dose Chemo with Autologous BMT
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Nov 20, 2019
Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation
Completed
- Lymphoma, B-Cell
- +2 more
- Autologous transplantation using rituxan/BEAM
- Autologous transplantation using Bexxar/BEAM
-
New Haven, Connecticut
- +35 more
Oct 21, 2021
Leukemia Trial in Aurora (BioIntelliSense BioButton Rechargable, Memora Health two-way patient engagement platform provided by
Recruiting
- Leukemia
- BioIntelliSense BioButton Rechargable
- Memora Health two-way patient engagement platform provided by RC
-
Aurora, ColoradoUniversity of Colorado Hospital
Apr 20, 2023
Bone Marrow Transplant Complications Trial in Boston (BMT-VR)
Recruiting
- Bone Marrow Transplant Complications
- BMT-VR
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Premature Ovarian Failure Trial in Qena (Autologous bone marrow transplantation)
Terminated
- Premature Ovarian Failure
- Autologous bone marrow transplantation
-
Qena, EgyptSouth Valley University, Qena Faculty of Medicine, Obstetrics an
Sep 20, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Chemo-induced Nausea and Vomiting Trial in Chicago (Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Granisetron Transdermal Patch
- +2 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Jun 7, 2022
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL, Infants With Very High Risk KMT2A B-ALL, Patients With CNS
Active, not recruiting
- Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL
- +2 more
- Murine CART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jan 11, 2022
Fluoroquinolone Resistance Prevalence Study
Recruiting
- Multiple Myeloma
-
Washington, District of Columbia
- +1 more
Apr 10, 2023
Identify Barriers to Cellular Therapies for People With Plasma
Recruiting
- Multiple Myeloma
- Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Nov 6, 2023
Multiple Myeloma Trial in Atlanta (BeEAM)
Completed
- Multiple Myeloma
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Oct 19, 2022
GVHD, Blood and Marrow Transplant (BMT) Trial in Stanford (high dose chemo and autologous hematopoietic cell transplant)
Completed
- Graft vs Host Disease
- Blood and Marrow Transplant (BMT)
- high dose chemotherapy and autologous hematopoietic cell transplant
-
Stanford, CaliforniaStanford University School of Medicine
Apr 7, 2020
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in
Completed
- Hematopoietic Neoplasm
- Dietary intake -Food Frequency Questionnaire
- Receptivity to Participating in Diet Interventions
-
Gainesville, FloridaUF Health Cancer Center
Sep 13, 2019
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)
Recruiting
- Sickle Cell Disease
- Bone Marrow Transplant (BMT)
- +7 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Sep 13, 2022